Musculoskeletal News and Research

RSS

New online training module greatly improves medical student clinical skills

An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.

22 May 2014

CHEO pediatric surgeon wins TELUS Award for mHealth Innovation

Local pediatric surgeon and entrepreneur Dr. Matthew Bromwich accepted the "TELUS Award for mHealth Innovation" at the 29th Annual CATAAlliance Innovation Awards Gala tonight.

22 May 2014

Physiotherapy for hip osteoarthritis questioned

Hip osteoarthritis is a prevalent and costly chronic musculoskeletal condition. Clinical guidelines recommend physiotherapy as treatment, although its effectiveness has never been proven.

22 May 2014

Innate immune response may warn of chronic multisite musculoskeletal pain

An enhanced innate immune response may be an indicator of the onset or prolongation of chronic, multisite musculoskeletal pain, cross-sectional study findings suggest.

19 May 2014

Study finds increased risk of hospitalization for heart failure in IBD patients

Heart failure hospitalisation more than doubles during inflammatory bowel disease (IBD) flares, according to a study of more than 5 million Danish people. The research was presented today at the Heart Failure Congress 2014, held 17-20 May, in Athens, Greece.

19 May 2014

Two new Manchester research centres aim at improving lives of people with arthritis

Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.

14 May 2014

Baylor receives $3.3M grant from NIAMS to advance research in autoimmune diseases

Baylor Research Institute has received a $3.3 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), one of the National Institutes of Health, to fund its Autoimmunity Center of Excellence.

14 May 2014

Esaote gets FDA clearance to market Virtual Navigator fusion imaging technology for ultrasound

Esaote North America announced today that it has received FDA clearance to market and sell its Virtual Navigator fusion imaging technology for ultrasound.

12 May 2014

Expanding Medicaid access increases use of subspecialty surgical services in New York State

Researchers in the department of surgery at the University of Michigan have found that expanding access to Medicaid in New York State increased beneficiaries' use of subspecialty surgical services.

8 May 2014

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Cedars-Sinai Heart Institute researchers have found that a commonly prescribed drug restores blood flow to oxygen-starved muscles of boys with Duchenne muscular dystrophy, a genetic muscle-wasting disease that rarely is seen in girls but affects one in 3,500 male babies, profoundly shortening life expectancy. It is the most common fatal disease that affects children.

8 May 2014

Being obese at age 25 places individuals at risk of severe level of obesity later in life

Exposure to long-term obesity has become more common with increases in obesity at younger ages. Researchers examined the relationship between BMI at age 25, obesity later in life, and biological indicators of health.

6 May 2014

DJOFL first quarter 2014 net sales increase 1.3% to $282.7 million

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its public reporting subsidiary, DJO Finance LLC, for the first quarter ended March 29, 2014.

29 Apr 2014

Neuropathic and psychogenic pain contribute to chronic musculoskeletal pain

A lack of appropriate treatment for neuropathic and psychogenic pain may cause patients with musculoskeletal pain to suffer a more chronic pain course, according to the latest results of an ongoing Japanese epidemiological study.

28 Apr 2014

NIAMS scientific director to receive 2014 Ross Prize in Molecular Medicine

John J. O'Shea, M.D., scientific director at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), has been named the 2014 recipient of the Ross Prize in Molecular Medicine, conferred by the Feinstein Institute's peer-reviewed, open-access journal Molecular Medicine.

25 Apr 2014

P4 pain scale found suitable for use in knee osteoarthritis

The P4 pain scale compares favorably with other commonly used measures for patients with severe knee osteoarthritis, a Canadian study has found.

22 Apr 2014

NBTY introduces Nature's Origin, a complete line of nutritional supplements

NBTY, Inc., a leading global manufacturer and distributor of high-quality vitamins and nutritional supplements, introduces Nature's Origin, its first complete line of vitamins, minerals and herbal supplements that are free from ingredients made with GMOs, preservatives, gluten and irradiation.

22 Apr 2014

Scientists lay groundwork for understanding immune responses in Lyme disease patients

A team of scientists led by Johns Hopkins and Stanford University researchers has laid the groundwork for understanding how variations in immune responses to Lyme disease can contribute to the many different outcomes of this bacterial infection seen in individual patients. A report on the work appears online April 16 in PLOS One.

21 Apr 2014

Northwestern Medicine study provides new insights on tissue scarring in scleroderma

A discovery by Northwestern Medicine scientists could lead to potential new treatments for breaking the cycle of tissue scarring in people with scleroderma.

21 Apr 2014

NICE recommends FIRMAGON for treating advanced hormone-dependent prostate cancer in adults with spinal metastases

The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON (degarelix) as an option for treating advanced hormone-dependent prostate cancer, only in adults with spinal metastases who present with signs or symptoms of spinal cord compression.

16 Apr 2014

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Janssen Research & Development, LLC ("Janssen") today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA™ (ibrutinib) to the U.S. Food and Drug Administration (FDA) by its collaboration partner Pharmacyclics, Inc.

8 Apr 2014

Musculoskeletal News and Research

New online training module greatly improves medical student clinical skills

CHEO pediatric surgeon wins TELUS Award for mHealth Innovation

Physiotherapy for hip osteoarthritis questioned

Innate immune response may warn of chronic multisite musculoskeletal pain

Study finds increased risk of hospitalization for heart failure in IBD patients

Two new Manchester research centres aim at improving lives of people with arthritis

Baylor receives $3.3M grant from NIAMS to advance research in autoimmune diseases

Esaote gets FDA clearance to market Virtual Navigator fusion imaging technology for ultrasound

Expanding Medicaid access increases use of subspecialty surgical services in New York State

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Being obese at age 25 places individuals at risk of severe level of obesity later in life

DJOFL first quarter 2014 net sales increase 1.3% to $282.7 million

Neuropathic and psychogenic pain contribute to chronic musculoskeletal pain

NIAMS scientific director to receive 2014 Ross Prize in Molecular Medicine

P4 pain scale found suitable for use in knee osteoarthritis

NBTY introduces Nature's Origin, a complete line of nutritional supplements

Scientists lay groundwork for understanding immune responses in Lyme disease patients

Northwestern Medicine study provides new insights on tissue scarring in scleroderma

NICE recommends FIRMAGON for treating advanced hormone-dependent prostate cancer in adults with spinal metastases

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News